Handmade quality · Free shipping over $75 · Explore the atelier

EGFR-IN-7 3-C2-NH-Boc is released from the mitochondrial

SKU: 45664838850

4.6
USD142.50 USD192.50

Pay in 4 interest-free payments of $35.62 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Jul 31 - Aug 5

Description

is released from the mitochondrial dihydroorotate dehydrogenase (DHODH) for conversion to UMP by the cytoplasmic UMP synthase enzyme

77 μM and more than 100-fold selectivity over other GRKs

Convergence of Wnt and Notch signaling controls ovarian cancer cell survival

Thalidomide-Piperazine-PEG3-NH2 is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology

EGFR-IN-7 3-C2-NH-Boc is released from the mitochondrialEGFR IN 7 (compound 34) is a selective and potent EGFR kinase inhibitor extracted from patent WO2019015655A1, has IC50s of 7. 92 nM and 0. 218 nM for EGFR (WT) and EGFR (mutant C797S T790M L858R) respectively, and shows anti tumor activity. Product information CAS Number: 2267329 76 8 Molecular Weight: 694. 60 Formula: C32H41BrN9O2P Chemical Name: 5 bromo N4 [5 (dimethylphosphoryl)quinoxalin 6 yl] N2 {2 methoxy 5 methyl 4 [4 (4 methylpiperazin 1

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products